جستجوی استاد راهنمای دانشگاهی

Martin Burkeمشاهده پروفایل

استاد

• Organic Chemistry
• Small-Molecule Synthesis
• Molecular Prosthetics
• +۷ مورد دیگر

Martin Burke is the May and Ving Lee Professor for Chemical Innovation and Professor of Chemistry at the University of Illinois Urbana-Champaign , with additional appointments in Biochemistry, Biomedical & Translational Sciences, and multiple campus institutes including the Beckman Institute and the Carl R. Woese Institute for Genomic Biology. Education B.S. Johns Hopkins University , 1998 Ph.D. Harvard University , 2003 M.D. Harvard Medical School , 2003 Research Interests Burke’s program centers on molecular prosthetics : the design, synthesis and application of small molecules that replicate or replace missing or dysfunctional proteins. His group pioneered iterative cross-coupling (ICC) using MIDA-protected haloboronic acids to automate the construction of complex natural products and function-oriented small molecules. Current projects target ion-channel replacement in cystic fibrosis, iron-transport restoration in anemia, and non-toxic antifungals that overcome drug resistance. Scientific Awards & Honors National Academy of Medicine (2021) AAAS Fellow (2021) ASCI Member (2021) iCON Award (2019) Mukaiyama Award, Japan (2019) ACS Nobel Laureate Award for Graduate Education (2017) Thieme-IUPAC Prize in Synthetic Organic Chemistry (2014) Elias J. Corey Award (2013) Arthur C. Cope Scholar Award (2011) Research Output & Impact Burke has authored >120 peer-reviewed articles, >30 patents, and his work has been cited >20,000 times. High-impact publications in Nature , Science , and Angewandte Chemie have advanced automated synthesis, molecular prosthetics, and cystic fibrosis therapeutics. Laboratory & Training The Burke Laboratories house a multidisciplinary team of graduate students, post-doctoral researchers, and physician-scientists developing next-generation molecular prosthetics. The group is supported by NIH, NSF, private foundations, and industry partnerships aimed at democratizing molecular innovation.

Liang Zhaoمشاهده پروفایل

استاد

• Pharmacometrics
• Drug Delivery Modeling
• Artificial Intelligence in Drug Development
• +۵ مورد دیگر

Liang Zhao, PhD, MAS, MBA, is a Professor in the Department of Bioengineering and Therapeutic Sciences within the Schools of Pharmacy and Medicine at the University of California, San Francisco (UCSF). Prior to joining UCSF, he served as director of the Division of Quantitative Methods and Modeling (DQMM) in the Office of Research and Standards in the Office of Generic Drugs in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) from 2015 to 2024. His professional career spans over 19 years with experience at Pharsight, Bristol Myers Squibb (BMS), MedImmune, and the FDA. Dr. Zhao's research focuses on pharmacometrics, drug delivery modeling, and artificial intelligence-based tools that impact drug development and regulatory decision-making. His work encompasses mechanistic models for brain drug delivery, regulatory science modeling and simulation, AI-driven drug discovery and development, drug interactions, biological availability, generic drugs, clinical pharmacology, therapeutic equivalency, computer simulation, and FDA regulatory processes. He has pioneered innovative approaches including model master files for model sharing and model-integrated evidence for generic product development and approval. His research integrates machine learning tools into pharmacometrics to advance drug delivery and bioequivalence assessment methodologies. Dr. Zhao has published over 120 articles and book chapters in prestigious journals. His recent publications demonstrate strong focus on applying advanced modeling techniques, machine learning algorithms, and pharmacometric approaches to solve complex problems in drug development and regulatory science. His work shows consistent innovation in developing quantitative methods to enhance bioequivalence assessment, improve drug product characterization, and support regulatory decision-making for generic drugs. FDA Group Recognition Award, FDA, 2024 Gary Neil Prize for Innovation in Drug Development, American Society for Clinical Pharmacology & Therapeutics (ASCPT), 2023 Commissioner's Special Citation, FDA, 2021 Humanitarian Award, Victims' Rights Foundation, 2020 30+ FDA CDER team and Individual Awards, CDER, FDA, 2011 Academic Award for Executive MBA Class 2009, Judge Business School, University of Cambridge, 2011 Dr. Zhao leads the Zhao Lab at UCSF, which advances drug development and regulatory science through cutting-edge research in pharmacometrics, drug delivery modeling, and artificial intelligence. His work bridges academic research with regulatory applications, demonstrating leadership in translating scientific innovations into practical regulatory frameworks. His experience across industry, regulatory agencies, and academia provides a unique perspective on drug development challenges and opportunities.

• Respiratory Drug Delivery
• Pulmonary Drug Delivery
• Inhalation Aerosols
• +۵ مورد دیگر

Professor Hak-Kim Chan of the Sydney Pharmacy School at the University of Sydney is a world-renowned expert in respiratory drug delivery, particularly pulmonary aerosols and inhalation therapies. With over 480 publications and 17,580+ Google Scholar citations, he has pioneered advancements in powder formulation , in silico modeling , and clinical applications of inhalation technologies. His work includes the development of FDA-approved diagnostics like Aridol™ (inhaled mannitol for asthma) and Bronchitol™ (for cystic fibrosis), and groundbreaking research on inhaled bacteriophage therapy to combat antibiotic-resistant respiratory infections. Education: BPharm (University Medal, 1983), PhD (1988), DSc (2009) from University of Sydney Professional Experience: Postdoc at University of Minnesota (1988–89), Scientist at Genentech Inc. (1992–95) Leadership: Executive Editor of Advanced Drug Delivery Reviews , Fellow of AAPS and RACI His research spans in vitro production methods, computational modeling of inhaler design, and in vivo imaging of aerosol deposition. Current projects focus on nanomedicine , phage therapy , and combating superbugs via inhalation routes. He has secured significant recognition for his work, including NHMRC case studies highlighting public health impacts. Professor Chan has supervised numerous researchers, including PhD student Grace YAU studying pulmonary probiotic delivery . His team's 10 patents (7 as first inventor) reflect practical innovations in dry powder inhalers , antimicrobial formulations , and drug stabilization technologies.

• Nanomedicine
• Drug Delivery Systems
• Cellular Uptake of Nanoparticles
• +۳ مورد دیگر

Anna Salvati is an Associate Professor specializing in nanomedicine and drug delivery systems. Her research focuses on nanoparticle-cell interactions, biomolecular corona formation, and the physicochemical properties governing nanomaterial behavior in biological environments. Key research themes include cellular uptake mechanisms, toxicity of nanomaterials, and nanoparticle targeting strategies. Recent publications highlight her work on nanoparticle stability, membrane interactions, and environmental impacts of microplastics. Her studies integrate multiomics approaches, advanced imaging, and interlaboratory validation to address challenges in nanomedicine design and safety testing. Current projects explore the role of high-density lipoproteins in nanoparticle functionality and the modulation of drug release kinetics through material engineering.

Jayne Ellisمشاهده پروفایل

استاد مدعو

• Wildlife Disease
• Wildlife Pathology
• Viral Pathogenesis
• +۳ مورد دیگر

Dr. Jayne Ellis, DVM, serves as Adjunct Faculty in the College of Natural Science and Mathematics at the University of Alaska Fairbanks (UAF). She concurrently works as an On-Call Wildlife Veterinarian for the Alaska Department of Fish and Game and teaches the necropsy laboratory for second-year veterinary students at UAF. Education Bachelor of Science in Wildlife Conservation Biology, Colorado State University Doctor of Veterinary Medicine (DVM), UAF-CSU Joint Program Dual residency training in Anatomic Pathology and Toxicology, Michigan State University (2 years) Fellowship year in Wildlife Pathology, University of California, Davis Research Interests Dr. Ellis’s investigative work centers on wildlife disease ecology and pathogenesis, with particular emphasis on viral infections affecting avian and mammalian species. Her recent projects investigate the spillover of highly pathogenic avian influenza A(H5N1) from birds into wild terrestrial mammals, as well as emerging respiratory viruses in Alaskan moose populations. Additional interests span toxicologic pathology, infectious disease surveillance in raptor populations, and comparative anesthesia protocols for endangered equids. Publications & Scientific Contributions Across 15 peer-reviewed articles and conference presentations from 2018-2023, Ellis has advanced understanding of viral transmission at the wildlife–domestic animal interface, described novel bacterial pathogens in wild birds, and refined anesthetic techniques for exotic ungulates. Her work integrates field surveillance, molecular diagnostics, and classic pathology to inform conservation and public health policy. Professional Licenses & Qualifications State of Alaska Veterinary License (active) Residency-trained and board-eligible in Anatomic Pathology Teaching & Outreach At UAF, Dr. Ellis leads hands-on necropsy laboratories that train future veterinarians in systematic post-mortem examination techniques essential to wildlife disease investigation. She also provides diagnostic pathology support to state wildlife agencies and collaborates with multi-institutional teams to monitor emerging zoonoses.

Marc Schneiderمشاهده پروفایل

استاد

• Colloidal drug delivery systems
• Nanoparticle and microparticle engineering
• Nanotechnology in pharmacy
• +۳ مورد دیگر

Prof. Dr. Marc Schneider holds a professorship in Biopharmaceutics and Pharmaceutical Technology at Saarland University's College of Pharmacy . His research focuses on colloidal drug delivery systems, particularly nanostructured and non-spherical particle engineering for overcoming biological barriers in pulmonary and transdermal applications. He leads an internationally recognized lab in Saarbrücken, collaborating with Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and trinational institutions. Research Highlights: Development of inhalable nano/microparticle systems Surface modification of gelatin nanoparticles Characterization of mucus-penetrating particles 3D printing for microneedle fabrication Atomic Force Microscopy (AFM) for nanoparticle analysis Selected Scientific Awards: European Journal of Pharmaceutics and Biopharmaceutics Best Paper Award (2018) for mucus-penetrating nanoparticles Recognized in 'Ausgezeichnete Orte im Land der Ideen' competition (2018) for 'Nano-Mais' drug delivery system Collaborative Networks: Co-editor for Advanced Drug Delivery Reviews special issue on biological barriers Key participant in trinational Master's program in Biomedicine with Strasbourg, Mainz, and Luxembourg Active in Controlled Release Society (CRS) conferences and local chapters

• Molecular Microbiology
• Bacterial Pathogenesis
• Antibiotic Resistance
• +۳ مورد دیگر

Jonathan Dennis, PhD, is a Professor in the Department of Biological Sciences at the University of Alberta. He specializes in Molecular Microbiology with a focus on bacterial pathogenesis, antibiotic resistance, and phage therapy. His research targets the Burkholderia cepacia complex (Bcc), a group of opportunistic pathogens causing severe infections in cystic fibrosis patients. He develops bacteriophage-based therapies to combat antibiotic-resistant bacteria. He teaches courses such as GENET 270, MICRB 316, and MICRB 516. His research combines genetic and genomic approaches to identify virulence factors in Bcc and explores phage isolation, characterization, and aerosol delivery for clinical applications. Key projects include phage-antibiotic synergies and phage therapy efficacy in animal models. He has pioneered the use of Galleria mellonella larvae and rice plant models for infection studies. Dr. Dennis leads a lab with expertise in phage genomics, synthetic biology, and respiratory infection treatments. His work aims to overcome antibiotic resistance through phage cocktails and modified phages. He collaborates on developing inhalable phage powders and investigates phage-mediated virulence reduction in bacteria.

Alexandra Piotrowski-Daspitمشاهده پروفایل

استادیار

• Gene Therapy
• Biomaterials
• Nanoparticle Delivery
• +۳ مورد دیگر

Dr. Alexandra Piotrowski-Daspit is an Assistant Professor in the Biomedical Engineering department and Internal Medicine – Pulmonary and Critical Care Medicine at the University of Michigan Medical School. She is a chemical/biological engineer with expertise in polymeric biomaterials for gene therapies, focusing on in vivo behavior of delivery vehicles and strategies to optimize biodistribution. Education: Ph.D. in Chemical/Biological Engineering Her research bridges polymer chemistry, gene delivery, and translational medicine, emphasizing in utero interventions and pulmonary targeting. Key areas include nanoparticle surface engineering, macrophage decoys, and computational pharmacokinetic modeling. Recent publications highlight systemic in utero gene editing for cystic fibrosis, poly(amine-co-ester) nanoparticle tunability, and mucosal vaccination platforms. She also explores miRNA therapies for congenital diaphragmatic hernia and triplex-forming PNAs for CFTR correction. PhRMA Foundation Awardee (2024) Her work involves interdisciplinary collaborations, DEI initiatives, and translational projects from postdoc foundations in W. Mark Saltzman’s lab. Labs like Saltzman and SCGE teams support her research.

Peter Barnesمشاهده پروفایل

استاد

• Respiratory Science
• Asthma
• COPD
• +۵ مورد دیگر

Professor Sir Peter Barnes is a leading figure in respiratory science at Imperial College London's National Heart and Lung Institute (NHLI) . As Professor of Thoracic Medicine , his work focuses on Asthma, COPD, and cellular senescence in lung disease , with over four decades of contributions to understanding inflammatory pathways and therapeutic innovations. Research Interests Mechanisms of chronic airway inflammation in Asthma and COPD Cellular senescence in lung aging and disease progression MicroRNA transfer via extracellular vesicles in COPD pathogenesis Targeted drug delivery for respiratory conditions Global health implications of lung disease Recent Publications highlight trends in: MicroRNA regulation of senescence and inflammation Extracellular vesicle dynamics in lung disease Biologics and corticosteroid efficacy in respiratory conditions Environmental factors influencing COPD and asthma Scientific Recognition Knighthood (2023) for services to respiratory science Fellow of the Royal Society (FRS) and Academy of Medical Sciences (FMedSci) Collaborative Leadership at NHLI has mentored numerous postdocs and researchers. His work intersects with global initiatives like GOLD (Global Initiative for COPD) , influencing clinical guidelines and public health policy.

Andrés J. Garcíaمشاهده پروفایل

استاد

• Bioengineering
• Regenerative Medicine
• Biomaterials
• +۷ مورد دیگر

Andrés J. García is the Executive Director of the Parker H. Petit Institute for Bioengineering & Bioscience and a Regents’ Professor in the George Woodruff School of Mechanical Engineering at Georgia Institute of Technology. His research focuses on engineered biomaterials for regenerative medicine, including tissue repair, inflammation modulation, and cell adhesion mechanisms. He co-founded three startups (CellectCell, CorAmi Therapeutics, iTolerance) and holds multiple patents in biomaterials and drug delivery systems. Education: Ph.D., University of Pennsylvania, 1996 M.S.E., University of Pennsylvania, 1992 B.S., Cornell University, 1991 Research Interests: García’s work integrates engineering, materials science, and cell biology to develop biomaterials that direct cellular responses. Key areas include: Biomaterial platforms for bone repair and vascularization Immunomodulatory hydrogels for islet transplantation Antibacterial hydrogels for implant infection control Organoid generation using synthetic hydrogels Mechanisms of cell adhesion and mechanotransduction Publications: Over 30+ peer-reviewed articles in Nature Communications , Science Advances , Biomaterials , and others, highlighting innovations in hydrogel design, stem cell therapies, and biomaterial-driven tissue repair. Awards: Member of both the National Academy of Engineering and National Academy of Medicine (2021), Clemson Award for Basic Research (2012), and Fellowships with the American Society of Mechanical Engineers and AAAS. Labs/Teams: Leads the García Laboratory, collaborating across disciplines to translate biomaterials research into clinical applications. Active in startup partnerships and federal grants (e.g., NSF, NIH).

Johan Ulrik Lindمشاهده پروفایل

دانشیار

• Additive Manufacturing
• Tissue Engineering
• Functional Materials
• +۶ مورد دیگر

Johan Ulrik Lind is an Associate Professor and Groupleader at the Department of Health Technology, Technical University of Denmark. His research focuses on cutting-edge biomedical engineering solutions including tissue engineering, bioprinting, and microphysiological systems. He actively contributes to additive manufacturing and functional materials development. Current Affiliation: Department of Health Technology, DTU Research Areas: 3D bioprinting, hydrogel technologies, microsystems engineering Expertise: UN Sustainable Development Goals for health and well-being Lind's work spans additive manufacturing for tissue engineering, functionalized biomaterials , and dynamic microphysiological systems . His recent publications highlight innovations in hydrogel formulation, bioink development, and particulate drug delivery systems. Notably, he holds a patent for transparent bioink formulation. He supervises multiple PhD projects including: micro-perfused bioartificial ovaries, embedded bioprinting of perfusable vasculatures, and 3D printed microsystems for tissue actuation. His research portfolio demonstrates strong interdisciplinary collaboration across engineering, biology, and pharmaceutical sciences.

Amber Martinمشاهده پروفایل

دانشیار بالینی

• Geriatric Pharmacy
• Clinical Pharmacotherapy
• Medication Management
• +۶ مورد دیگر

Amber Martin, Pharm.D., BCPS, is an Associate Clinical Professor at Auburn University Harrison College of Pharmacy. Her professional address is 1330p Walker Building, Auburn, AL 36849, and she can be reached at martiam@auburn.edu. Education: Pharm.D., Auburn University Harrison College of Pharmacy, 2007 Dr. Martin specializes in geriatric pharmacotherapy, COPD management, diabetes treatment, and medication regimen reviews for skilled nursing facilities. She integrates sterile compounding education into the curriculum and coordinates skills laboratory experiences for pharmacy students. Her research focuses on age-related medication challenges, chronic disease management, and interdisciplinary clinical education. She has presented nationally on topics such as diabetes care, geriatric pharmacotherapy, and inhaler techniques for elderly COPD patients, with publications in journals like Current Pharmacy Teaching and Learning and Expert Review of Clinical Pharmacology . Dr. Martin contributes to experiential education through introductory and advanced pharmacy practice experiences (IPPEs/APPEs) and PGY-1 residency training. She collaborates with multidisciplinary teams at East Alabama Medical Center and has delivered regional continuing education lectures on COPD, vitamin D, and GI therapies.

• Neuroanesthesia
• Neurocritical Care
• Cerebrovascular Diseases
• +۳ مورد دیگر

Mehmet S. Ozcan, MD is an Associate Professor of Anesthesiology at Yale School of Medicine and Section Chief of Neuroanesthesia. He specializes in neurosurgical and critical care anesthesia, focusing on cerebrovascular diseases, intracranial tumors, and intraoperative neurophysiologic monitoring. His roles include Co-Chief of the Division of Adult Multispecialty Anesthesia. Dr. Ozcan completed medical training at Istanbul University Cerrahpasa School of Medicine (1996), followed by residency and fellowships in anesthesiology and critical care at the University of Florida (2003–2005). He previously practiced at the University of Illinois Chicago and University of Oklahoma before joining Yale. Research interests include ethical considerations in neurocritical care, cerebrovascular management, and neuroanesthesia techniques. He has published extensively in peer-reviewed journals, with recent work focusing on medical device transparency, entropy analysis in anesthesia, and lipid emulsion therapies. Professional activities include serving on the Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Scientific Affairs Committee and editorial roles for journals like Anesthesia and Analgesia and Journal of Neurosurgical Anesthesia .

• Internal Medicine Nursing
• Chronic Obstructive Pulmonary Disease (COPD) Care
• Cultural Competency in Nursing
• +۵ مورد دیگر

Assoc. Prof. Dr. Yasemin CEYHAN is an accomplished academic in nursing, currently serving as an Associate Professor at Kırşehir Ahi Evran University's Faculty of Health Sciences, Department of Nursing. She has been a full-time faculty member since 2013, initially as a Research Assistant (2013-2020) and subsequently as a Doctoral Teaching Member (2020-present). She holds multiple administrative positions including Head of Department (2020-present), Faculty Council Member (2022-present), and Quality Committee Member (2024-present). Dr. CEYHAN completed her Bachelor's Degree in Nursing at Ahi Evran University (2007-2011), followed by a Master's Degree in Nursing at Erciyes University (2012-2015), and earned her Doctorate in Internal Medicine Nursing from Erciyes University (2015-2019). She has completed numerous specialized courses in statistical analysis, meta-analysis, and healthcare research methodology. Her research primarily focuses on Internal Medicine Nursing with particular expertise in Chronic Obstructive Pulmonary Disease (COPD) management, cultural competency in nursing practice, and patient self-management in chronic diseases. She has developed significant expertise in psychometric evaluation of nursing instruments and has contributed substantially to understanding the relationship between cultural sensitivity and nursing care effectiveness. Her work bridges nursing practice with psychological, cultural, and physiological aspects of patient care. Analysis of her publication record reveals a clear evolution from descriptive studies to sophisticated analytical research employing structural equation modeling and randomized controlled trials. Her recent work demonstrates increasing methodological rigor with a focus on mediation and moderation effects in complex patient care scenarios, particularly in COPD management where she examines intricate relationships between symptoms, psychological factors, and self-management behaviors. Poster Presentation 3rd Prize (2014) from Eskişehir Osmangazi University Dr. CEYHAN has successfully supervised multiple Master's theses and currently mentors additional graduate students. She has secured and led several significant research projects funded by TÜBA, TÜBİTAK, and university research funds, focusing on chronic disease management, cultural competency assessment tools, and COPD patient care. Her research portfolio demonstrates a strong commitment to evidence-based nursing practice and instrument development. As an active member of the Turkish Respiratory Research Association (since 2018) and the Turkish Nurses Association (since 2015), Dr. CEYHAN maintains a robust collaborative research network that spans multiple Turkish universities, particularly Erciyes University. Her work reflects a team-oriented research approach with numerous co-authored publications demonstrating interdisciplinary collaboration.

• Respiratory Medicine
• Asthma Pathophysiology
• Eosinophilic Lung Disorders
• +۳ مورد دیگر

Parameswaran Krishna Nair is a Professor of Medicine and the Frederick E. Hargreave Teva Innovation Chair in Airway Diseases at McMaster University, with a clinical role as Staff Respirologist at the Firestone Institute for Respiratory Health, St. Joseph’s Healthcare Hamilton. His work focuses on complex obstructive airway diseases, severe asthma, and eosinophilic lung disorders, integrating immunology, hematology, and imaging specialists in multidisciplinary care. He leads an advanced airway diseases fellowship training program. University: McMaster University Clinical Affiliation: Firestone Institute for Respiratory Health, St. Joseph’s Healthcare Hamilton His research explores airway autoimmunity, biologics for inflammatory disorders, and pulmonary imaging techniques like hyperpolarized ¹²⁹Xe MRI. Key studies include mechanisms of eosinophilic asthma, corticosteroid dependence, and post-acute sequelae of COVID-19 with rheumatological implications. Recent publications analyze biologic therapies (benralizumab, mepolizumab), ventilation heterogeneity in asthma, and sputum immunoglobulins as biomarkers. Awards include the Frederick E. Hargreave Teva Innovation Chair in Airway Diseases. Scientific Awards: Frederick E. Hargreave Teva Innovation Chair He contributes to clinical guidelines, therapeutic trials, and autoantibody research in severe respiratory diseases.